These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37469536)

  • 1. Ivabradine effects on COVID-19-associated postural orthostatic tachycardia syndrome: a single center prospective study.
    Abdelnabi M; Saleh Y; Ahmed A; Benjanuwattra J; Leelaviwat N; Almaghraby A
    Am J Cardiovasc Dis; 2023; 13(3):162-167. PubMed ID: 37469536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postural orthostatic tachycardia syndrome as a sequela of COVID-19.
    Ormiston CK; Świątkiewicz I; Taub PR
    Heart Rhythm; 2022 Nov; 19(11):1880-1889. PubMed ID: 35853576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivabradine for the Treatment of Postural Orthostatic Tachycardia Syndrome: A Systematic Review.
    Gee ME; Watkins AK; Brown JN; Young EJA
    Am J Cardiovasc Drugs; 2018 Jun; 18(3):195-204. PubMed ID: 29330767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivabradine in Postural Orthostatic Tachycardia Syndrome: A Review of the Literature.
    Tahir F; Bin Arif T; Majid Z; Ahmed J; Khalid M
    Cureus; 2020 Apr; 12(4):e7868. PubMed ID: 32489723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Approaches to Dysautonomia in Childhood, with a Special Focus on Long COVID.
    Buchhorn R
    Children (Basel); 2023 Feb; 10(2):. PubMed ID: 36832445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience.
    Ruzieh M; Sirianni N; Ammari Z; Dasa O; Alhazmi L; Karabin B; Grubb B
    Pacing Clin Electrophysiol; 2017 Nov; 40(11):1242-1245. PubMed ID: 28846151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single centre experience of ivabradine in postural orthostatic tachycardia syndrome.
    McDonald C; Frith J; Newton JL
    Europace; 2011 Mar; 13(3):427-30. PubMed ID: 21062792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome.
    Taub PR; Zadourian A; Lo HC; Ormiston CK; Golshan S; Hsu JC
    J Am Coll Cardiol; 2021 Feb; 77(7):861-871. PubMed ID: 33602468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postural Tachycardia Syndrome and COVID-19: Focus on Ivabradine Therapy.
    Dixit K; Frishman WH
    Cardiol Rev; 2024 May-Jun 01; 32(3):279-284. PubMed ID: 36729924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postural orthostatic tachycardia syndrome and other related dysautonomic disorders after SARS-CoV-2 infection and after COVID-19 messenger RNA vaccination.
    Gómez-Moyano E; Rodríguez-Capitán J; Gaitán Román D; Reyes Bueno JA; Villalobos Sánchez A; Espíldora Hernández F; González Angulo GE; Molina Mora MJ; Thurnhofer-Hemsi K; Molina-Ramos AI; Romero-Cuevas M; Jiménez-Navarro M; Pavón-Morón FJ
    Front Neurol; 2023; 14():1221518. PubMed ID: 37654428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivabradine in Postural Orthostatic Tachycardia Syndrome: Preliminary Experience in Children.
    Delle Donne G; Rosés Noguer F; Till J; Salukhe T; Prasad SK; Daubeney PEF
    Am J Cardiovasc Drugs; 2018 Feb; 18(1):59-63. PubMed ID: 29027608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postural orthostatic tachycardia syndrome after COVID-19 vaccination.
    Teodorescu DL; Kote A; Reaso JN; Rosenberg C; Liu X; Kwan AC; Cheng S; Chen PS
    Heart Rhythm; 2024 Jan; 21(1):74-81. PubMed ID: 38176772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting heart rate variability as a diagnostic marker of cardiovascular dysautonomia in postural tachycardia syndrome.
    Inbaraj G; Udupa K; Vasuki PP; Nalini A; Sathyaprabha TN
    J Basic Clin Physiol Pharmacol; 2023 Jan; 34(1):103-109. PubMed ID: 36367272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Ivabradine on the Heart Rate and Sympathovagal Balance in Postural Tachycardia Syndrome Patients.
    Barzilai M; Jacob G
    Rambam Maimonides Med J; 2015 Jul; 6(3):. PubMed ID: 26241226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate and heart rate variability comparison between postural orthostatic tachycardia syndrome versus healthy participants; a systematic review and meta-analysis.
    Swai J; Hu Z; Zhao X; Rugambwa T; Ming G
    BMC Cardiovasc Disord; 2019 Dec; 19(1):320. PubMed ID: 31888497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postural Orthostatic Tachycardia Syndrome: Mechanisms and New Therapies.
    Mar PL; Raj SR
    Annu Rev Med; 2020 Jan; 71():235-248. PubMed ID: 31412221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivabradine in children with postural orthostatic tachycardia syndrome: a retrospective study.
    Towheed A; Nesheiwat Z; Mangi MA; Karabin B; Grubb BP
    Cardiol Young; 2020 Jul; 30(7):975-979. PubMed ID: 32498748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suspected COVID-19 mRNA Vaccine-Induced Postural Orthostatic Tachycardia Syndrome.
    Maharaj N; Swarath S; Seecheran R; Seecheran V; Panday A; Seecheran N
    Cureus; 2023 Jan; 15(1):e34236. PubMed ID: 36852364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection.
    Ocher RA; Padilla E; Hsu JC; Taub PR
    Case Rep Cardiol; 2021; 2021():7809231. PubMed ID: 34471549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis.
    Kanjwal K; Karabin B; Kanjwal Y; Grubb BP
    Int J Med Sci; 2010 Mar; 7(2):62-7. PubMed ID: 20309394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.